Nicholas Marsh
Fortuna: 25 086 $ al 31/08/2026
Fortuna: 25 086 $ al 31/08/2026
Nicholas Marsh worked as a Director of Pharmacology at Adnexus.
Prior to that, he obtained a doctorate degree from The University of Chicago in 1995.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Northern Venture Trust Plc
Northern Venture Trust Plc Investment ManagersFinance Functions as a private equity fund 0,01 % | 01/11/2025 | 33.000 ( 0,01 % ) | 25 086 $ | 31/08/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.